Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.8%

4 terminated/withdrawn out of 41 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

12%

5 trials in Phase 3/4

Results Transparency

0 of 20 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

22(64.7%)

Phase 1

3(8.8%)

Phase 4

3(8.8%)

Early Phase 1

3(8.8%)

Phase 3

2(5.9%)

Phase 2

1(2.9%)

34Total

N/A(22)

Phase 1(3)

Phase 4(3)

Early Phase 1(3)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (41)

Showing 20 of 41 trials

NCT07340463Phase 2Recruiting

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Role: lead

NCT07108140Early Phase 1Terminated

Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

Role: collaborator

NCT06285279Phase 1Recruiting

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

Role: lead

NCT06957678Enrolling By Invitation

AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data

Role: collaborator

NCT06226896Active Not Recruiting

Effects of Dapagliflozin on Progression of Alport Syndrome

Role: lead

NCT06376214Not ApplicableRecruiting

Daratumumab for Patients With Light Chain Amyloidosis

Role: lead

NCT04210791Enrolling By Invitation

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Role: lead

NCT05978661Phase 1Recruiting

FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Role: lead

NCT06020287Completed

The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach

Role: lead

NCT05863936Phase 3Unknown

Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

Role: lead

NCT02298335Not ApplicableCompleted

Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational Study

Role: lead

NCT04507945Phase 1Unknown

Stablishment of Prevention and Treatment System for Intestinal Dysfunction

Role: lead

NCT04134065Early Phase 1Unknown

the Effect of Vitamin D in Crohn's Disease

Role: lead

NCT03828071Not ApplicableCompleted

Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis

Role: lead

NCT03282253Unknown

Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis

Role: lead

NCT01451489Not ApplicableTerminated

The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis

Role: lead

NCT02819245Not ApplicableUnknown

Impact of Age on Surgical Outcome of Adolescent Idiopathic Scoliosis

Role: lead

NCT02691598Phase 4Unknown

Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following Severe Acute Pancreatitis

Role: lead

NCT02388555Completed

Perspective Analysis of Coronal Imbalance in Degenerative Scoliosis

Role: lead

NCT00885547Not ApplicableTerminated

Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis

Role: lead